We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02413736
Recruitment Status : Recruiting
First Posted : April 10, 2015
Last Update Posted : September 27, 2022
Scandinavian Sarcoma Group
Information provided by (Responsible Party):
Heikki Joensuu, Helsinki University Central Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2028
Estimated Study Completion Date : May 2028